• en

+7 (495) 782-23-42

  • Home
  • About us
  • Team
    • Management team
    • Advisory Board
  • Portfolio companies
    • Exited investments
    • Current investments
  • News
  • Contact

News

Home / News / Pipeline Therapeutics Appoints Julie Iwashita as Vice President of Clinical Operations
3
dec

Pipeline Therapeutics Appoints Julie Iwashita as Vice President of Clinical Operations

SAN DIEGO, December 3, 2020 – Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, today announced the appointment of Julie Iwashita as the company’s Vice President of Clinical Operations. Ms. Iwashita brings more than 30 years of experience guiding global neurology and other clinical development programs through the U.S. Food and Drug Administration (FDA) and other global health authorities.

“I am delighted to welcome Julie to Pipeline Therapeutics to spearhead our clinical development efforts,” said Carmine Stengone, President & CEO of Pipeline Therapeutics. “Julie’s extensive experience in managing drug candidates through the clinic, across a variety of therapeutic areas, will benefit us greatly as we move our neuroregenerative candidates through clinical studies and assemble the data packages needed for eventual NDA submissions.”

About Pipeline Therapeutics

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company's lead clinical program, PIPE-505, is currently enrolling patients in a phase 1/2a study to treat sensorineural hearing loss (SNHL) associated with speech-in-noise disability. The company also has a portfolio of programs addressing a range of neurological disorders, including development candidate PIPE-307 which is focused on remyelination to treat multiple sclerosis.

https://www.pipelinetherapeutics.com/news/pr_12-03-2020.php

News

25
dec

PanDx raises seed investment to develop a versatile catheter to treat severe GI conditions

More
23
dec

Botkin.AI raises $2M to further develop its medical AI platform

More
3
dec

Pipeline Therapeutics Appoints Julie Iwashita as Vice President of Clinical Operations

More

All rights to the materials of this website are held by the partners of the RusBio Ventures Limited Partnership (Investment Partnership Agreement dated 10 October 2014)